Intelligence · Clinical Pipeline
R&D Pipeline Programs
ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.
- Programs indexed
- 20,548
- Companies
- 1,769
- Drugs tracked
- 4,797
Quick answer
NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.
-
Letrozole -Berberine
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Polycystic Ovary Syndrome
1 trial -
Lidocaine Hydrochloride 2% Injection Solution
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Colorectal Cancer
1 trial -
Lidocaine Hydrochloride, Injectable
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Primary Liver Cancer
1 trial -
Linaclotide
Second Affiliated Hospital of Xi'an Jiaotong University
Bowel Preparation
1 trial -
Liraglutide
The First People's Hospital of Lianyungang
Ischemic Stroke
1 trial -
Losartan
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Healthy
1 trial -
Low potassium content vegetables
Xiyuan Hospital of China Academy of Chinese Medical Sciences
End-stage Renal Disease
1 trial -
Luo-Fu-Shan Plaster
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Arthritis, Rheumatoid
1 trial -
Luspatercept
The First People's Hospital of Lianyungang
Transfusion-dependent Non-severe Aplastic Anemia
1 trial -
Luvometinib
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Langerhans Cell Histiocytosis (LCH)
1 trial -
Medical Treatment
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Carotid Artery Stenting
1 trial -
Medical treatment
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Decompensated Cirrhosis
1 trial -
Medication for opioid-use disorder (MOUD) for opioid-use disorder (OUD)
BRIGHT MINDS BIOSCIENCES INC.
HIV Infections
1 trial -
Medium-quantity lipid-based nutrient supplement (MQ-LNS)
United Therapeutics Europe Ltd
Undernutrition
1 trial -
Meiji Yogurt Group
Xiyuan Hospital of China Academy of Chinese Medical Sciences
H. Pylori Infection
1 trial -
Metformin hydrochloride sustained release tablets
The First People's Hospital of Lianyungang
Osteoarthritis
1 trial -
Metformin pretreatment before ovarian stimulation
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Metformin
1 trial -
Methylphenidate HCl ER tablets 1
BRIGHT MINDS BIOSCIENCES INC.
Attention Deficit Hyperactivity Disorder
1 trial -
Metoclopramide 10mg
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Oral Cancer
1 trial -
Mitoxantrone hydrochloride liposome injection
The First People's Hospital of Lianyungang
Diffuse Large B-cell Lymphoma
1 trial -
Mitoxantrone hydrochloride liposome injection30mg/m2
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Acute Myeloid Leukemia
1 trial -
Modafinil Oral Tablet
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Healthy
1 trial -
Morphine
BRIGHT MINDS BIOSCIENCES INC.
Sleep Deprivation
1 trial -
Multi-component Interventions
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Multimorbidity
1 trial
Frequently asked questions
What is the NovaPharmaNews pipeline directory?
It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.
Where does pipeline data come from?
Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.
How do I find pipeline programs by company or phase?
Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.
Data attribution and licensing: Data sources